Image Gallery - Boston Scientific
Need an image of a Boston Scientific product? View and download high-res images of a variety of Boston Scientific products in the image gallery.
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Nov 4, 2024 · Cortex Inc. acquisition to complement Boston Scientific’s electrophysiology portfolio with solution to advance treatment of complex atrial fibrillation (AFib).
Boston Scientific Announces Results for First Quarter 2024
Apr 24, 2024 · Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis...
News Releases - Boston Scientific
Nov 4, 2024 · At Boston Scientific, unwavering commitment to patients translates into the highest levels of research, quality, and innovation. Read the latest press releases.
Boston Scientific Announces Results For Fourth Quarter and Full …
Feb 2, 2022 · Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational1 basis...
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
Sep 17, 2024 · Silk Road acquisition adds pioneering treatment option to Boston Scientific portfolio for patients suffering from carotid artery disease.
President of Boston Scientific's Peripheral Interventions business. "With its second cleared indication, the FilterWire EZ System offers innovation and versatility to treat a variety of lesions and cases seen in every day practice." The carotid arteries are located on either side of the neck and are the main conduit through which blood flows
Boston Scientific to Participate in the 2024 UBS Global Healthcare ...
Nov 5, 2024 · Boston Scientific will participate in an upcoming healthcare conference in November 2024. A live webcast and replay will be available. Read more.
Boston Scientific Obtains CE Mark for ACURATE Prime™ Aortic …
Aug 27, 2024 · ACURATE Prime Aortic Valve System is the newest transcatheter aortic valve replacement (TAVR) technology in Boston Scientific’s structural heart portfolio.
Boston Scientific Announces Results for Second Quarter 2024
Jul 24, 2024 · "We delivered a quarter marked by exceptional performance,” said Mike Mahoney, chairman and CEO, Boston Scientific. Read the July 24, 2024 announcement. Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent on a reported basis, 16.1 percent on an operational1 ...